EUVIMEDEUVIMED entdecken
Leserbrief

Is a 2‐week regimen of tecovirimat sufficient for the treatment of Mpox (monkeypox) in advanced HIV patients with a low CD4 cell count?

Joo-Hee Hwang, Jeong-Hwan Hwang

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29617 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Joo-Hee Hwang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, Republic of Korea. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHumansCD4 Lymphocyte CountTreatment OutcomeMaleAntiviral AgentsFemaleAdultMiddle AgedMpox, Monkeypox

Substanzen

Antiviral Agents

Autor:innen und Institutionen

  • Department of Internal Medicine, Jeonbuk National University Medical School and Hospital, Jeonju, Republic of Korea.
  • Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea.

Zitieren

APA

Hwang, J. H., & Hwang, J. H. (2024). Is a 2‐week regimen of tecovirimat sufficient for the treatment of Mpox (monkeypox) in advanced HIV patients with a low CD4 cell count?. Journal of Medical Virology. https://doi.org/10.1002/jmv.29617

Vancouver

Hwang JH, Hwang JH. Is a 2‐week regimen of tecovirimat sufficient for the treatment of Mpox (monkeypox) in advanced HIV patients with a low CD4 cell count?. Journal of Medical Virology. 2024. doi:10.1002/jmv.29617

BibTeX
@article{Hwang2024,
  author = {Hwang, Joo-Hee and Hwang, Jeong-Hwan},
  title = {Is a 2‐week regimen of tecovirimat sufficient for the treatment of Mpox (monkeypox) in advanced HIV patients with a low CD4 cell count?},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29617}
}
Kostenlos starten →